Integrative multi-omic analysis of NLRP3 inflammasome dysregulation and subtyping for personalized treatment in acute myeloid leukemia
Abstract Acute myeloid leukemia (AML) is a devastating form of blood cancer characterized by uncontrolled growth and impaired maturation of myeloid precursor cells in the bone marrow. Despite advancements in treatment strategies, the prognosis for AML patients remains poor. The NLRP3 inflammasome, a...
Saved in:
| Main Authors: | Hong Zhang, Linlin Yang, Yukexin Liu, Dongju Wang, Liming Shi, Changyu Tian |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-07-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-02383-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NLRP11 is required for canonical NLRP3 and non-canonical inflammasome activation during human macrophage infection with mycobacteria
by: Mateusz Szczerba, et al.
Published: (2025-05-01) -
Expression of lymphocyte subsets in the bone marrow of patients with acute myeloid leukemia and its influence on prognosis
by: NIE Jinhong, et al.
Published: (2025-07-01) -
Research progress on NLRP3 inflammasome regulation of periodontitis
by: LI Xuejing, et al.
Published: (2024-02-01) -
The NLRP3 inflammasome in urogenital cancers: structure, dual function, and therapeutic potential
by: Weiming Sun, et al.
Published: (2025-07-01) -
Verteporfin attenuates NLRP3 inflammasome activation to alleviate gout arthritis flares
by: Daniel C. Shippy, et al.
Published: (2025-07-01)